News Releases

Date	Title
Aug 10, 2020	Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business Update
Jul 21, 2020	Homology Medicines Appoints Jeff Poulton to the Board of Directors
May 26, 2020	Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program
May 12, 2020	Homology Medicines Announces Presentations on its In Vivo Gene Therapy and Gene Editing Programs and Commercial Manufacturing Platform at the American Society of Gene & Cell Therapy Annual Meeting
May 07, 2020	Homology Medicines Reports First Quarter 2020 Financial Results and Recent Highlights
Apr 29, 2020	Homology Medicines Announces Presentations at Upcoming American Society for Gene & Cell Therapy Annual Meeting
Mar 16, 2020	Homology Medicines Announces Peer-Reviewed Publication of HMI-102 Investigational Gene Therapy Demonstrating Restoration of Normal Metabolic Pathway in PKU Disease Model
Mar 12, 2020	Homology Medicines Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Accomplishments
Feb 20, 2020	Homology Medicines to Participate in Upcoming Investor and Scientific Conferences
Feb 13, 2020	Homology Medicines Presents New Data Characterizing AAVHSCs as Potential Gene Therapies for Nervous System Disorders